ceritinib
4 products
4 abstracts
Abstract
Identification of pharmaceutics with selective activity against melanoma-associated leptomeningeal disease using patient-derived circulating tumor cells.Org: H. Lee Moffitt Cancer Center and Research Institute,
Abstract
Dosage optimization in drug development: An FDA Project Optimus analysis of postmarketing requirements issued to repair the cracks.Org: Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Oncology Center of Excellence,
Abstract
Anaplastic lymphoma kinase (ALK) and ROS 1– positive advanced NSCLC: A real-world institutional experience.Org: NIMS - Nizam's Institute of Medical Sciences, NIMH - National Institute of Mental Health, Nimble Science, Amazon, Google Cloud, Munich, Germany,
Abstract
A real-world study of ALK fusion detection, treatment patterns, and survival outcomes of patients with advanced non–small-cell lung cancer (aNSCLC) in Brazil.Org: Oncoclinicas & Co - Medica Scientia Innovation Research (MEDSIR), Rio De Janeiro, Brazil, Oncoclinícas, Oncoclínicas Bahia, Hospital Santa Izabel,
Product
Various ALK inhibitorsProduct
targeted therapiesProduct
ALK TKIsProduct
ALK-TKI